Literature DB >> 15451404

Altered hippocampal expression of calbindin-D-28k and calretinin in GABA(B(1))-deficient mice.

Elisabeth Rüttimann1, Claire-Marie Vacher, Martin Gassmann, Klemens Kaupmann, Herman Van der Putten, Bernhard Bettler.   

Abstract

Balb/c GABA(B(1))(-/-) mice develop complex epileptiform activity, including spontaneous and audiogenic generalized seizures, 6-8 weeks after birth. The neuronal systems involved in these epilepsies have not been identified yet. Because the hippocampus is critically involved in epileptiform activity, we now investigated whether this brain region exhibits seizure-related alterations. Using semi-quantitative immunohistochemistry, we studied the temporal and cellular hippocampal expression pattern of two seizure-sensitive calcium-binding proteins, calbindin-D-28k and calretinin, in GABA(B(1))(-/-) mice. One month after birth, before the onset of overt epileptiform activity, wild-type (WT) and GABA(B(1))(-/-) mice exhibit comparable expression profiles for the two calcium-binding proteins. Three months after birth, once the epileptic phenotype is established, we observe clear alterations in the expression of calcium-binding proteins in the dentate gyrus area. GABA(B(1))(-/-) mice exhibit a 50% decline in the staining intensity of calbindin-D-28k expressing neurons and a 70% increase in the number of calretinin-positive neurons when compared to WT littermates. Six months after birth, the down-regulation of calbindin-D-28k protein is even more pronounced, while the calretinin expression in GABA(B(1))(-/-) mice reverts to the pattern seen in WT littermates. Our data demonstrate that the absence of functional GABA(B) receptors causes epileptiform activity through a mechanism that crucially involves dentate gyrus granule cells, and that this pathological activity is accompanied by adaptive changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451404     DOI: 10.1016/j.bcp.2004.07.019

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS.

Authors:  Valentina Emmanuele; Angels Garcia-Cazorla; Hua-Bin Huang; Jorida Coku; Beatriz Dorado; Etty P Cortes; Kristin Engelstad; Darryl C De Vivo; Salvatore Dimauro; Eduardo Bonilla; Kurenai Tanji
Journal:  J Neurol Sci       Date:  2012-04-05       Impact factor: 3.181

2.  Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.

Authors:  Patricia Rivera; Sergio Arrabal; Antonio Vargas; Eduardo Blanco; Antonia Serrano; Francisco J Pavón; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Neuroanat       Date:  2014-03-17       Impact factor: 3.856

3.  Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus.

Authors:  Marika Nosten-Bertrand; Caroline Kappeler; Céline Dinocourt; Cécile Denis; Johanne Germain; Françoise Phan Dinh Tuy; Soraya Verstraeten; Chantal Alvarez; Christine Métin; Jamel Chelly; Bruno Giros; Richard Miles; Antoine Depaulis; Fiona Francis
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

Review 4.  Complex GABAB receptor complexes: how to generate multiple functionally distinct units from a single receptor.

Authors:  Chanjuan Xu; Wenhua Zhang; Philippe Rondard; Jean-Philippe Pin; Jianfeng Liu
Journal:  Front Pharmacol       Date:  2014-02-11       Impact factor: 5.810

5.  Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.

Authors:  Patricia Rivera; Sergio Arrabal; Manuel Cifuentes; Jesús M Grondona; Margarita Pérez-Martín; Leticia Rubio; Antonio Vargas; Antonia Serrano; Francisco J Pavón; Juan Suárez; Fernando Rodríguez de Fonseca
Journal:  Front Neuroanat       Date:  2014-06-27       Impact factor: 3.856

6.  Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus.

Authors:  Christina T LaGamma; William W Tang; Ashlea A Morgan; Josephine Cecelia McGowan; Rebecca A Brachman; Christine A Denny
Journal:  Front Mol Neurosci       Date:  2018-11-06       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.